SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 263 filers reported holding SAGE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $156,000 | -13.3% | 2,083 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $180,000 | -71.7% | 2,083 | -53.7% | 0.00% | -71.4% |
| Q3 2018 | $636,000 | +31.4% | 4,500 | +49.9% | 0.01% | +16.7% |
| Q1 2018 | $484,000 | -2.0% | 3,002 | 0.0% | 0.01% | +9.1% |
| Q4 2017 | $494,000 | -41.4% | 3,002 | -77.8% | 0.01% | -42.1% |
| Q3 2017 | $843,000 | -21.7% | 13,528 | 0.0% | 0.02% | -20.8% |
| Q2 2017 | $1,077,000 | +12.1% | 13,528 | 0.0% | 0.02% | +14.3% |
| Q1 2017 | $961,000 | +39.1% | 13,528 | 0.0% | 0.02% | +40.0% |
| Q4 2016 | $691,000 | +10.9% | 13,528 | 0.0% | 0.02% | +7.1% |
| Q3 2016 | $623,000 | – | 13,528 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
| TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
| Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
| Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
| RA Capital Management | 455,173 | $74,972,000 | 6.27% |
| Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
| Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
| GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
| BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
| Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |